Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Dualyx logo — Discovery and development of highly innovative biologicals f...

Dualyx

Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases.

Founded 2021 Belgium Belgium 6 employees Series A Total: $40.00M Biotechnology, Health Care

General Information

Company Name Dualyx
Founded Year 2021
Location Belgium Belgium
Employees 6
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Dualyx. To contact Dualyx, visit dualyx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Dualyx

Dualyx, established in 2021 and headquartered in Belgium, is a dynamic player in the Biotechnology and Health Care industries. The company is centered around the discovery and development of highly innovative biologicals designed to treat autoimmune and rare diseases, addressing high unmet medical needs.

The company's recent financial milestone occurred on May 15, 2023, when it secured a substantial €40.00M Series A investment. This funding round attracted significant attention from prominent investors, including BioGeneration Ventures, Forbion, Andera Partner, Fountain Healthcare Partners, PMV, V-Bio Ventures, VIB, Gemma Frisius Fund, and HTGF | High-Tech Gruenderfonds.

Given its strategic focus on innovative therapeutic solutions and strong investor backing, Dualyx is well-positioned for impactful advancements in addressing critical health conditions. This positions the startup as an attractive opportunity for investors seeking to support pioneering health solutions with significant market potential.

Taxonomy: Biologicals, Autoimmune diseases, Rare diseases, Drug discovery, Therapeutic innovation, Biopharmaceuticals, Medical treatment, Patient care, Unmet medical needs, Clinical development, Healthcare innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €40.00M 9
BioGeneration Ventures Forbion Andera Partner
BioGeneration Ventures, Forbion +7
15 May 2023
Venture Round Undisclosed 1
BioGeneration Ventures
BioGeneration Ventures
01 Jan 2020

Dualyx Alternatives & Competitors

View All Alternatives
Dualyx vs
Angitia Biopharmaceuticals
Angitia Biopharmaceuticals United States

Developing innovative medicines to address serious musculoskeletal diseases

Series B
52 employees
Biopharma, Biotechnology
Dualyx vs
Hansa Biopharma
Hansa Biopharma Sweden

We are dedicated to bring innovative treatments to people living with rare immunological diseases.

Post-IPO Equity
144 employees
Biotechnology, Health Care
Dualyx vs
Tridek-One
Tridek-One France

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases

Venture round
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About Dualyx

Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases.
Dualyx was founded in 2021.
Dualyx is headquartered in Belgium.
Dualyx operates in Biotechnology and Health Care. Its work centres on Biologicals, Autoimmune diseases, Rare diseases and Drug discovery.
Dualyx has approximately 6 employees.
Dualyx has completed 2 funding rounds, raising a total of $40.00M. The latest funding stage is Series A.
Top alternatives and competitors to Dualyx include Angitia Biopharmaceuticals, Hansa Biopharma, Tridek-One, Healx, Amolyt Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dualyx and Angitia Biopharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Dualyx, https://bouncewatch.com/company/dualyx, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes